Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025. On December 22, Canaccord raised the firm’s price target on Guardant Health to $125 from $100 with a Buy rating on the shares. The firm expects the life science sector to maintain its current upward trend well into 2026. Guardant Health remains Canaccord’s top recommendation, as the firm believes that the stock offers the best balance of limited downside and strong growth potential compared to its peers.
Mizuho also raised the firm’s price target on Guardant Health Inc. (NASDAQ:GH) on December 17 to $120 from $100 and maintained an Outperform rating on the shares. As part of its 2026 outlook, the firm updated its price targets within the medical devices and diagnostics sector. While valuations have returned to near two-year highs following Q3 2025 earnings, the firm suggests that there is room for further multiple expansion. This growth is contingent on healthcare emerging as the preferred defensive play while market capital continues to rotate through volatile AI and cryptocurrency mega-trades.
On December 15, Bank of America also raised the firm’s price target on Guardant Health to $120 from $100 and kept a Buy rating on the shares. This decision was made as BofA is revising its price targets across the Life Sciences and Diagnostic Tools sector as part of a 2026 outlook. The firm anticipates that current industry headwinds will subside, leading to a normalized market environment by 2026. The firm believes that the primary catalyst for growth will be a resurgence in Biopharma spending, prompting BofA to prioritize companies with significant exposure to R&D.
Guardant Health Inc. (NASDAQ:GH) is a precision oncology company that provides blood and tissue tests and data sets in the US and internationally.
While we acknowledge the potential of GH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.